For help on how to get the results you want, see our search tips.
104 results
Categories
Human Remove Human filter
Referral type
Article 5(11) referrals (prior to January 2010) Remove Article 5(11) referrals (prior to January 2010) filter
Article 13 Remove Article 13 filter
Article 107i procedures Remove Article 107i procedures filter
Article 30 referrals Remove Article 30 referrals filter
Medicine
Referrals Remove Referrals filter
-
List item
Referral: Valtrex
valaciclovir, associated names: Zelitrex, Talavir, Valaciclovir Allen, Valherpes, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 13/07/2010, Last updated: 25/03/2014 -
List item
Referral: Hydroxyethyl starch solutions for infusion
hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 23/10/2013, EC decision date: 19/12/2013, Last updated: 06/03/2014 -
List item
Referral: Targocid and associated names
teicoplanin, associated names: Targocid, Teicomid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2013, EC decision date: 12/09/2013, Last updated: 03/01/2014 -
List item
Referral: Sandimmun and associated names
ciclosporin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 31/10/2013, Last updated: 20/12/2013 -
List item
Referral: Sandimmun Neoral and associated names
ciclosporin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 31/10/2013, Last updated: 20/12/2013 -
List item
Referral: Flupirtine-containing medicines
flupirtine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 05/09/2013, Last updated: 21/11/2013 -
List item
Referral: Tazocin
piperacillin, tazobactam, associated names: Tazobac, Tazocel, Tazonam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/02/2011, Last updated: 19/11/2013 -
List item
Referral: Augmentin
amoxicillin, clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013 -
List item
Referral: Numeta G13%E and Numeta G16%E emulsion for infusion
Article 107i procedures
Status: CMDh final position, opinion/position date: 18/09/2013, Last updated: 27/09/2013 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone, ethinyl estradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013 -
List item
Referral: Tetrazepam-containing medicines
tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, Last updated: 18/07/2013 -
List item
Referral: Zinacef
cefuroxime sodium, associated names: Curocef, Curoxim, Curoxim Monovial, Curoxima, Curoxime, Zinnat, Zinocep, Zinocep Vena, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 10/09/2012, Last updated: 29/01/2013 -
List item
Referral: Zinnat
cefuroxime axetil, associated names: Cefuroxima Solasma, Cefuroxima Allen, Cefuroxima Duncan, Elobact, Nivador, Oraxim, Selan, Tilexim, Zinadol, Zipos, Zoref, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 23/08/2012, Last updated: 29/01/2013 -
List item
Referral: Flolan
epoprostenol, associated names: Epoprostenol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 08/08/2012, Last updated: 14/09/2012 -
List item
Referral: Tavanic
levofloxacin, associated names: Levofloxacin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/05/2012, EC decision date: 31/07/2012, Last updated: 12/09/2012 -
List item
Referral: Priorix
measles, mumps and rubella vaccine (live), Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/03/2012, EC decision date: 25/05/2012, Last updated: 19/06/2012 -
List item
Referral: Femara
letrozole, associated names: Femar, Fémara, Loxifan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 15/03/2012, EC decision date: 22/05/2012, Last updated: 12/06/2012 -
List item
Referral: Lipitor
atorvastatin, associated names: Atorvastatin, Atorvastatina Nostrum, Atorvastatina Parke-Davis, Atorvastatina Pharmacia, Cardyl, Edovin, Liprimar, Orbeos, Prevencor, Sortis, Tahor, Texzor, Torvast, Totalip, Xarator, Zarator, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/09/2010, EC decision date: 13/12/2010, Last updated: 10/04/2012 -
List item
Referral: Norvasc
amlodipine, associated names: Amlodipine Pfizer, Amlodipino, Amlor, Istin, Monopina, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/07/2011, EC decision date: 07/10/2011, Last updated: 29/03/2012 -
List item
Referral: Tienam
imipenem, cilastatin, associated names: Conet, Imipem, Primaxin, Tenacid, Zienam, Article 30 referrals
Status: European Commission final decision, opinion/position date: 16/12/2010, EC decision date: 10/03/2011, Last updated: 20/02/2012 -
List item
Referral: Diflucan
fluconazole, associated names: Fluconazole, Fungustatin, Fungata, Triflucan, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 02/09/2011, Last updated: 02/02/2012 -
List item
Referral: Protium
pantoprazole, associated names: Anagastra, Apton, Controloc, Eupantol, Inipomp, Pantec, Pantecta, Pantipp, Panto-Byk-20 / 40 / IV, Pantoc, Pantoloc, PantoLomberg, Pantopan, Pantorc, Pantozol, Peptazol, Rifun, Somac, Ulcotenal, Zurcal, Zurcale, Zurcazol, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/12/2009, EC decision date: 15/04/2010, Last updated: 17/01/2012 -
List item
Referral: Vascace Plus
cilazapril, hydrochlorothiazide, associated names: Co-Inhibace, Dynorm Plus, Inhibace Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/10/2010, EC decision date: 21/01/2011, Last updated: 09/11/2011 -
List item
Referral: Atacand Plus
candesartan, hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Losec
omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011